Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$99.53 - $127.75 $1.35 Million - $1.73 Million
-13,528 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$122.75 - $135.17 $955,854 - $1.05 Million
-7,787 Reduced 36.53%
13,528 $1.7 Million
Q2 2021

Aug 16, 2021

BUY
$118.19 - $131.5 $717,058 - $797,810
6,067 Added 39.79%
21,315 $2.65 Million
Q1 2021

May 17, 2021

SELL
$111.18 - $119.74 $63,150 - $68,012
-568 Reduced 3.59%
15,248 $1.8 Million
Q4 2020

Feb 16, 2021

BUY
$100.57 - $117.14 $1.59 Million - $1.85 Million
15,816 New
15,816 $1.85 Million
Q1 2019

May 15, 2019

SELL
$82.45 - $93.79 $3.67 Million - $4.17 Million
-44,470 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$85.8 - $99.49 $3.82 Million - $4.42 Million
44,470 New
44,470 $4.05 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.